Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Bednar

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|November 4, 2000
Stroke: antithrombin versus antiplatelet therapyM M Bednar
Neurosurgery|February 1, 1990
Role of leukocytes and 5-lipoxygenase products in induction of cerebral edemaM M Bednar
Stroke|April 3, 1999
Antiplatelet therapy in acute cerebral ischemiaM M Bednar, C E Gross
Neurological Research|August 10, 1999
Aspirin reduces experimental cerebral blood flow in vivoM M Bednar, C E Gross
The Surgical Clinics of North America|April 1, 1995
Modifying the host response to injury. The future of trauma careJ C Hebert, M O'Reilly, M M Bednar
Advances in Experimental Medicine and Biology|January 1, 1983
Prostaglandins as mediators and modulators of the kallikrein-kinin systemC P Vio, M M Bednar, J C McGiff
Neurological Research|December 1, 1993
Tissue plasminogen activator: comparison of dose and route of administration in a rabbit model of thromboembolic strokeM M Bednar, S J Raymond, C E Gross
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agentM J Miller, M M Bednar, J C McGiff
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1984
Renal metabolism of sulindac: functional implicationsM J Miller, M M Bednar, J C McGiff
Stroke|December 1, 1990
Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic strokeM M Bednar, T McAuliffe, S Raymond, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|November 4, 2000
Stroke: antithrombin versus antiplatelet therapyM M Bednar
Neurosurgery|February 1, 1990
Role of leukocytes and 5-lipoxygenase products in induction of cerebral edemaM M Bednar
Stroke|April 3, 1999
Antiplatelet therapy in acute cerebral ischemiaM M Bednar, C E Gross
Neurological Research|August 10, 1999
Aspirin reduces experimental cerebral blood flow in vivoM M Bednar, C E Gross
The Surgical Clinics of North America|April 1, 1995
Modifying the host response to injury. The future of trauma careJ C Hebert, M O'Reilly, M M Bednar
Advances in Experimental Medicine and Biology|January 1, 1983
Prostaglandins as mediators and modulators of the kallikrein-kinin systemC P Vio, M M Bednar, J C McGiff
Neurological Research|December 1, 1993
Tissue plasminogen activator: comparison of dose and route of administration in a rabbit model of thromboembolic strokeM M Bednar, S J Raymond, C E Gross
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agentM J Miller, M M Bednar, J C McGiff
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1984
Renal metabolism of sulindac: functional implicationsM J Miller, M M Bednar, J C McGiff
Stroke|December 1, 1990
Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic strokeM M Bednar, T McAuliffe, S Raymond, et al.
Pageof 5